Kufa University   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Kufa Iraq (1987)

Organization Overview

First Clinical Trial
2010
NCT01953796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Head of Department of Psychiatry | Kufa University | medical college/ kufa university

Active Ingredients

Drugs in Phase 4 Trials (1)

vitamin c (1 trial)

Drugs in Phase 3 Trials (1)

medicinal charcoal (1 trial)

Drugs in Phase 1 Trials (2)

ketoprofen (orudis) (1 trial)

sertraline (zoloft) (2 trials)

Drugs in Other Trials (5)

acetaminophen (tylenol) (1 trial)

clomifene (clomid) (1 trial)

diclofenac (voltaren) (1 trial)

escitalopram (lexapro) (1 trial)

ginkgo biloba (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 1)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Disease (Phase 1)

Stress, Psychological (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9